The new horizons of molecular diagnosis: do we still need conventional microbiology?

D. Cirillo (Milan, Italy)

Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination

Number: 6

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Cirillo (Milan, Italy). The new horizons of molecular diagnosis: do we still need conventional microbiology?. School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The new era of diagnostics: will it ever start? Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship Year: 2019
From traditional bacteriology to rapid molecular methods: the revolution is going on Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012
From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016
The new perspectives in chest imaging: back to the future? Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process? Year: 2020
COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
Current and emerging approaches to the genetic diagnosis of chILDs Source: International Congress 2014 – Interstitial lung disease (ILD) in children Year: 2014
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020
Facts and perspectives in the development of new diagnostics Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008
NORDSTAR: paving the way for a new era in asthma research Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019 Year: 2020
Scene-setting: why do we need genomics and proteomics to understand pathology? Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004
Modern molecular lung cancer diagnostics – how to use and interpret it wisely Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018
New technologies in bronchoscopy: which are still research tools and which are ready for clinical use? Source: Annual Congress 2010 - PG13 Core Curriculum Postgraduate Course: Interventional pulmonology Year: 2010
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021
HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018
What kind of emphasis do we need in clinical research to enable personalised respiratory medicine? Source: Eur Respir J, 55 (1) 1901866; 10.1183/13993003.01866-2019 Year: 2020